Breaking News Instant updates and real-time market news.

CSCO

Cisco

$47.09

-1.34 (-2.77%)

, INTC

Intel

$48.10

-0.89 (-1.82%)

12:49
11/10/18
11/10
12:49
11/10/18
12:49

5G could be enough to lift cloud over tech hardware stocks, Barron's says

5G is coming, and it could be enough to light the cloud that has descended on technology hardware stocks, Al Root writes in this week's edition of Barron's. Apple (AAPL) is cutting phone production, automotive markets are slowing, industrial markets are decelerating, and all cyclical stocks have suffered as a result, the report notes, adding. But Intel (INTC) says 5G will offer 10 times less latency, 50 times more speed and 1,000 times more capacity, while Cisco Systems (CSCO) predicts that internet traffic will grow more than 20% a year until at least 2021, which translates in a lot of data that will require 5G infrastructure, the report adds. 5G could usher in an era of unconstrained data transfer, Root writes. Reference Link

CSCO

Cisco

$47.09

-1.34 (-2.77%)

INTC

Intel

$48.10

-0.89 (-1.82%)

AAPL

Apple

$204.31

-4.18 (-2.00%)

  • 12

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 26

    Nov

CSCO Cisco
$47.09

-1.34 (-2.77%)

10/15/18
WBLR
10/15/18
NO CHANGE
WBLR
Outperform
Arista higher after William Blair uncovers 'game-changing' Pentagon win
William Blair analyst Jason Ader says he recently learned from a federal value-added reseller contact that Arista Networks (ANET) has won a multiyear award with the Department of Defense for the unclassified piece of the Pentagon network, which encompasses 80,000 ports across multiple facilities. Shares of Arista Networks are up 3%, or $7.13, to $229.50 in premarket trading. The analyst's contact estimates the size of the contract at roughly $100M over multiple years, shared among Arista, Aruba, and the VAR. The contract win was a competitive displacement of Cisco Systems (CSCO), and includes Arista for core switching and routing, and Aruba for edge switching, Ader tells investors in a research note. He points out that the award is currently under protest by Cisco. While the deal by itself "should be a needle-mover" for Arista, it also represents a "game-changing development for the company in the U.S. federal vertical, where it has had very limited penetration historically," Ader contends. He believes the win "could open many new doors in the future" for Arista, both in Department of Defense and other government agencies. Ader reiterates an Outperform rating on Arista.
11/02/18
OPCO
11/02/18
NO CHANGE
Target $50
OPCO
Outperform
Cisco likely to report in-line quarter based on channel checks, says Oppenheimer
Oppenheimer analyst Ittai Kidron maintain an Outperform rating and $50 price target on Cisco Systems ahead of the company's quarterly results, telling investors that based on channel checks in the U.S. and Europe, he expects an in-line report. Kidron says he is "slightly more cautious" on the January quarter, but still expects the company to meet consensus estimates.
10/18/18
DBAB
10/18/18
NO CHANGE
DBAB
Buy
Deutsche Bank presents path to $75 per share for Cisco Systems
Deutsche Bank analyst Vijay Bhagavath is out with a research note highlighting a "Bull Case View" on Cisco Systems, which presents a "line of sight" to $75 per share. This represents "60% outperformance potential, based on a fairly modest" assumptions, Bhagavath tells investors. The assumptions include a 16 times enterprise value to free cash flow multiple on his $4.55 fiscal 2021 free cash flow per share scenario. The analyst's bull case for fiscal 2021 calls for a 7% sales growth scenario at 65% gross margin, 35% operating margin, and low-teens free cash flow growth. Bhagavath keeps a Buy rating on shares of Cisco.
10/17/18
BARD
10/17/18
INITIATION
BARD
Outperform
Proofpoint assumed with an Outperform at Baird
Baird analyst Jonathan Ruykhaver assumed coverage on Proofpoint (PFPT) with an Outperform rating and $130 price target. The analyst calls the stock's valuation "compelling," noting that Proofpoint's email security solution is among the best-rated technologies from industry experts, and saying he has a very high regard for the executive team. Additionally, Ruykhaver views the threat of increased competition from established providers like Cisco (CSCO) and Symantec (SYMC) to be "muted."
INTC Intel
$48.10

-0.89 (-1.82%)

11/07/18
JEFF
11/07/18
NO CHANGE
Target $30
JEFF
Buy
Jefferies sees 'watershed events' boosting AMD datacenter share 10-fold
Three "watershed events" over the next six months will materially improve AMD's (AMD) competitive position in datacenter, Jefferies analyst Mark Lipacis tells investors in a research note. The world's first 7nm graphics processing unit will be available in Q4, the world's first 7nm server micro processing unit will be available in Q2 of 2019, and Amazon Web Services (AMZN) is deploying AMD Server MPU instances at a 10% discount to Intel (INTC) now, the analyst writes following AMD's Datacenter Day. He believes these three events position AMD to increase its market share to 30% from 3% in the $29B datacenter market over the next three-to-five years. Lipacis reiterates a Buy rating on shares of AMD with a $30 price target. The stock in premarket trading is up 56c, or 3%, to $21.24.
11/08/18
STFL
11/08/18
NO CHANGE
Target $58
STFL
Hold
Qualcomm price target lowered to $58 from $62 at Stifel
Stifel analyst Kevin Cassidy lowered his price target on Qualcomm (QCOM) to $58 from $62 following the company's quarterly report, noting that MSM shipments are expected to decline about 20% in fiscal Q1, 50% of which is due to Apple (AAPL) now using Intel (INTC) modems. He is impressed with the 5G traction highlighted by management and believes Qualcomm's lead in 5G may encourage Apple to settle, but various litigation issues keep Cassidy on the sidelines with a Hold rating on Qualcomm shares.
11/07/18
PIPR
11/07/18
NO CHANGE
Target $20
PIPR
Neutral
Applied Optoelectronics price target lowered to $20 from $29 at Piper Jaffray
Piper Jaffray analyst Troy Jensen lowered his price target on Applied Optoelectronics (AAOI) to $20 after its Q3 results, saying the company posted another "disappointing quarter" with "execution missteps" and market share loss to competitors. The analyst believes that Finisar (FNSR) and Intel (INTC) have likely gained share as "transceiver shipments to a key account were delayed due to quality problems with 25g lasers". The analyst keeps his Neutral rating and a cautious stance on Applied Optoelectronics based on its "high degree of customer concentration and persistent execution problems."
10/26/18
BNCH
10/26/18
NO CHANGE
Target $100
BNCH
Buy
Mellanox a 'prized' target for 'host of buyers,' says Benchmark
After CNBC reported that Mellanox (MLNX) has hired an advisor to explore strategic alternatives, including a possible sale, Benchmark analyst Gary Mobley said it is difficult to verify the story but he believes the company would "represent a prized M&A target for a host of buyers," including potentially Nvidia (NVDA), Intel (INTC), Broadcom (AVGO), Marvell (MRVL) and "even" IBM (IBM). The analyst, who added that Mellanox's "initial apathy" toward prior M&A talks with Marvell was part of the reason Starboard got involved, keeps a Buy rating on Mellanox shares with a $100 price target.
AAPL Apple
$204.31

-4.18 (-2.00%)

11/08/18
ADAM
11/08/18
NO CHANGE
Target $75
ADAM
Buy
Qualcomm price target lowered to $75 from $86 at Canaccord
Canaccord analyst T. Michael Walkley lowered his price target on Qualcomm (QCOM) to $75 from $86 despite strong Q4 results, citing the loss of iPhone business combined with a soft smartphone market as the reason for the price change. His price assumptions take into account share buybacks and settling the licensing disputes with Apple (AAPL) and Huawei, he noted. Walkley maintained his Buy rating on Qualcomm shares.
11/08/18
MSCO
11/08/18
NO CHANGE
Target $253
MSCO
Overweight
Apple price target raised to $253 from $226 at Morgan Stanley
Morgan Stanley analyst Katy Huberty said she thinks the market is underestimating both the growth and value impact of Apple's (AAPL) Services business, which she sees being the key growth driver for Apple over the next five years. Following the firm's survey, which signaled spending increases over the next year, she tells investors in a new note that she is confident Apple can sustain annual Services growth of greater than 20% over the next five years. However, consensus is predicting Apple's Services growth rate slows to the mid teens by FY20, noted Huberty, who points out that her Services forecast is 11% above consensus over the next four years. Though the market was negative about the changes Apple plans to make to its financial disclosures, she views the change as a corroborating data point that Apple is approaching a services-led margin inflection, comparing it to when Amazon (AMZN) began breaking out AWS revenue and profits at the start of 2015. Following the firm's Apple survey, Huberty raised her price target on Apple shares to $253 from $226 and keeps an Overweight rating on the shares.
11/09/18
11/09/18
DOWNGRADE
Target $92

Neutral
Skyworks downgraded to Neutral on iPhone uncertainty at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Vivek Arya downgraded Skyworks (SWKS) to Neutral from Buy and lowered his price target on the shares to $92 from $120 after cutting his calendar 2019 pro forma EPS view by about 8% following the company's "disappointing" December quarter outlook. While Arya sees potential for Skyworks to expand into the new premium filter market and strength in its non-smartphone markets, he also believes the core high-end smartphone market has now matured and doesn't think content gains can offset unit weakness until perhaps the 5G cycle begins in earnest. The analyst, who now projects Skyworks' FY19 sales growth at only about 1%, down from his 7% prior forecast, believes Apple (AAPL) iPhone uncertainty could persist, he added.

TODAY'S FREE FLY STORIES

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.